1. Disparities in Gastric Cancer Chemotherapy Between the East and West
    Atsushi Ohtsu et al, 2006, Journal of Clinical Oncology CrossRef
  2. Texture Analysis of Breast DCE-MRI Based on Intratumoral Subregions for Predicting HER2 2+ Status
    Hecheng Lu et al, 2020, Frontiers in Oncology CrossRef
  3. Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer
    Yiting Geng et al, 2014, International Journal of Clinical Oncology CrossRef
  4. CURRENT POINT OF VIEW ON PROGNOSTIC AND PREDICTIVE ROLES AND PRACTICAL APPLICATION OF HER2 RECEPTOR’S DETECTION. LITERATURE REVIEW
    D. L. Rotin et al, 2020, Russian Journal of Biotherapy CrossRef
  5. HER2 expression and its clinicopathological features in resectable gastric cancer
    Yoshiki Kataoka et al, 2013, Gastric Cancer CrossRef
  6. A Complete Response Case of Gastric Cancer to Intravenous and Intraperitoneal Paclitaxel Combined with S-1 and Trastuzumab
    Nobumitsu Shiina et al, 2013, Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) CrossRef
  7. B Cell Epitope-Based Vaccination Therapy
    Yoshie Kametani et al, 2015, Antibodies CrossRef
  8. Intergenerational comparison of 5-HT3RA in the prevention of chemotherapy-induced nausea and vomiting in gastric cancer patients receiving cisplatin-based chemotherapy: an observational study using a Japanese administrative claims database
    Yuji Kunitomi et al, 2021, Supportive Care in Cancer CrossRef
  9. Targeting Oncogene Addiction for Cancer Therapy
    Sonia Thapa et al, 2021, Oncogenes and Tumor Suppressor Genes [Working Title] CrossRef
  10. HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial)
    null null et al, 2015, Gastric Cancer CrossRef
  11. HER2-positive gastric cancer
    Narikazu Boku, 2014, Gastric Cancer CrossRef
  12. Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer
    Hong-Zhi Shi et al, 2017, World Journal of Gastroenterology CrossRef
  13. Development ofHER2-targeted Therapies for Gastrointestinal Cancer
    Kentaro Sawada et al, 2020, European Oncology & Haematology CrossRef
  14. HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice
    Federica Grillo et al, 2016, World Journal of Gastroenterology CrossRef
  15. A novel gene–protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity
    Yasunori Nishida et al, 2015, Gastric Cancer CrossRef
  16. Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China
    Guo-Shuang Shen et al, 2016, World Journal of Gastroenterology CrossRef
  17. GRAM domain-containing protein 1B (GRAMD1B), a novel component of the JAK/STAT signaling pathway, functions in gastric carcinogenesis
    Puja Khanna et al, 2017, Oncotarget CrossRef
  18. Trastuzumab単剤投与が著効し長期寛解を得た胃癌術後リンパ節転移の1例
    Yu Sawada et al, 2011, Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) CrossRef
  19. Current and emerging therapies in unresectable and recurrent gastric cancer
    Erin Jou et al, 2016, World Journal of Gastroenterology CrossRef
  20. HER2 testing in gastric cancer: An update
    Lucas Faria Abrahao-Machado et al, 2016, World Journal of Gastroenterology CrossRef
  21. Study of prognostic indicators and Her2neu expression in gastric adenocarcinomas – A tertiary care centre study
    Ravi M Swami et al, 2021, Indian Journal of Pathology and Oncology CrossRef